NCT07768670 AI-Based Personalized Exercise Prescription Through Mobile Health on Physical Activity and Health Outcomes in Older Adults: A Feasibility Study
| NCT ID | NCT07768670 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Tennessee, Knoxville |
| Condition | Feasibility Studies |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-10-01 |
| Primary Completion | 2026-12-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2026-10-01 with a primary completion date of 2026-12-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research is to investigate the feasibility, acceptability, appropriateness, and preliminary efficacy of a wearable and artificial intelligence-driven mobile application-based exercise prescription grounded in self-determination theory (SDT) and behavioral change techniques (BCTs) among older adults. As no data exists on the feasibility of AI-driven exercise programs grounded in SDT and multiple BCTs specifically for older adults, this will be a pioneering study to explore the feasibility of wearable and AI-driven exercise program protocols and the rates of acceptance and appropriateness of the exercise prescription intervention among older adults. In addition, this study will test the preliminary efficacy of the intervention on physical activity (PA), mental health, and quality of life. This study follows the National Institute of Health (NIH) stage model, and it represents stage 1b of the NIH stage model, which emphasizes the feasibility and actionable processes for delivering a new health intervention. Specifically, this study will: 1.Evaluate the research protocol feasibility of a wearable and AI-driven mobile application-based exercise prescription grounded in SDT and BCTs (of goal setting, self-monitoring, graded task, and demonstration) on older adults over 8 weeks 2. Evaluate the acceptability and appropriateness of a wearable, AI-driven, mobile application-based exercise prescription grounded in SDT and BCTs among older adults over 8 weeks. 3. Evaluate the preliminary impact of a wearable and AI-driven mobile application-based exercise prescription grounded in SDT and BCTs on older adult PA (steps per day and daily duration of light PA and Moderate-vigorous PA), sedentary time, sleep, mental health (depression and anxiety), and quality of life.
Eligibility Criteria
Inclusion Criteria: * Be aged 65 years or older. * Own a smartphone (Android or iOS) compatible with study applications. * Have reliable access to the internet or Wi-Fi. * Demonstrate basic digital literacy sufficient to operate a smartphone (e.g., ability to open applications, navigate simple interfaces, and follow on-screen instructions), with or without initial guidance from the research staff. * Be able to safely engage in physical activity, as determined by the Physical Activity Readiness Questionnaire for Everyone (PAR-Q+) or physician approval if indicated. * Report engaging in less than 150 minutes of moderate-to-vigorous physical activity (MVPA) per week. * Be able to communicate in English sufficiently to complete study procedures and assessments. Exclusion Criteria: * Are younger than 65 years of age. * Do not own a compatible smartphone (Android or iOS) or do not have reliable internet/Wi-Fi access. * Are deemed unable to safely participate in physical activity based on the screening process (including PAR-Q+, STEADI, and research staff assessment), or do not obtain required physician clearance when indicated. * Currently meet or exceed 150 minutes of moderate-to-vigorous physical activity (MVPA) per week. * Are unable to communicate in English sufficiently to understand study procedures, provide informed consent, or complete study-related assessments. * Have any medical, physical, or cognitive condition that, in the judgment of the research team, would make participation unsafe or prevent completion of study procedures.
Contact & Investigator
Zan Gao, PhD
PRINCIPAL INVESTIGATOR
University Of Tennessee,knoxville
Frequently Asked Questions
Who can join the NCT07768670 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Feasibility Studies. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07768670 currently recruiting?
Yes, NCT07768670 is actively recruiting participants. Contact the research team at pael@utk.edu for enrollment information.
Where is the NCT07768670 trial being conducted?
This trial is being conducted at Knoxville, United States.
Who is sponsoring the NCT07768670 clinical trial?
NCT07768670 is sponsored by The University of Tennessee, Knoxville. The principal investigator is Zan Gao, PhD at University Of Tennessee,knoxville. The trial plans to enroll 20 participants.